1
|
Cheng SH, Lee SY, Lee HH. Harnessing the Power of Radiotherapy for Lung Cancer: A Narrative Review of the Evolving Role of Magnetic Resonance Imaging Guidance. Cancers (Basel) 2024; 16:2710. [PMID: 39123438 PMCID: PMC11311467 DOI: 10.3390/cancers16152710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2024] [Revised: 07/22/2024] [Accepted: 07/29/2024] [Indexed: 08/12/2024] Open
Abstract
Compared with computed tomography (CT), magnetic resonance imaging (MRI) traditionally plays a very limited role in lung cancer management, although there is plenty of room for improvement in the current CT-based workflow, for example, in structures such as the brachial plexus and chest wall invasion, which are difficult to visualize with CT alone. Furthermore, in the treatment of high-risk tumors such as ultracentral lung cancer, treatment-associated toxicity currently still outweighs its benefits. The advent of MR-Linac, an MRI-guided radiotherapy (RT) that combines MRI with a linear accelerator, could potentially address these limitations. Compared with CT-based technologies, MR-Linac could offer superior soft tissue visualization, daily adaptive capability, real-time target tracking, and an early assessment of treatment response. Clinically, it could be especially advantageous in the treatment of central/ultracentral lung cancer, early-stage lung cancer, and locally advanced lung cancer. Increasing demands for stereotactic body radiotherapy (SBRT) for lung cancer have led to MR-Linac adoption in some cancer centers. In this review, a broad overview of the latest research on imaging-guided radiotherapy (IGRT) with MR-Linac for lung cancer management is provided, and development pertaining to artificial intelligence is also highlighted. New avenues of research are also discussed.
Collapse
Affiliation(s)
- Sarah Hsin Cheng
- Department of Clinical Education and Training, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan;
| | - Shao-Yun Lee
- Department of Medical Education, Taichung Veterans General Hospital, Taichung 407, Taiwan;
| | - Hsin-Hua Lee
- Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan
- Ph.D. Program in Environmental and Occupational Medicine, Kaohsiung Medical University and National Health Research Institutes, Kaohsiung 807, Taiwan
- Department of Radiation Oncology, Faculty of Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
- Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan
| |
Collapse
|
2
|
Tekatli H, Palacios MA, Schneiders FL, Haasbeek CJA, Slotman BJ, Lagerwaard FJ, Senan S. Local control and toxicity after magnetic resonance imaging (MR)-guided single fraction lung stereotactic ablative radiotherapy. Radiother Oncol 2023; 187:109823. [PMID: 37516364 DOI: 10.1016/j.radonc.2023.109823] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 07/19/2023] [Accepted: 07/20/2023] [Indexed: 07/31/2023]
Abstract
PURPOSE Magnetic resonance imaging (MR)-guided radiotherapy permits continuous intrafraction visualization and use of automatic triggered beam delivery, with use of smaller planning target volumes (PTV). We report on long-term clinical outcomes following MR-guided single fraction (SF) lung SABR on a 0.35 T linac. MATERIALS AND METHODS Details of patients treated with SF-SABR for lung tumors were accessed from an ethics approved institutional database. A breath-hold 3D MR simulation scan was performed using a true FISP sequence, followed by a breath-hold 3D CT scan. The gross tumor volume (GTV) was first contoured on the breath-hold CT scan, which was then compared with contours on the 3D MR scan, before the GTV was finalized. SABR plans used step-and-shoot IMRT beams to a PTV derived by adding a 5 mm margin to the breath-hold GTV, and a 3 mm gating window was used. SABR was delivered during repeated breath-holds, using automatic beam gating with continuous visualization of the GTV in a sagittal MR plane. RESULTS Between 2018-2022, 50 consecutive patients were treated, and 69% had a primary non-small cell lung cancer. Median PTV was 11.2 cc (range 3.9-53.5); 80% of GTV's were located ≤2.5 cm from the chest wall. Prescribed doses were 34 Gy (in 58%), 30 Gy (32%), or between 20-28 Gy (10%). After a median follow-up of 18.1 months (95% CI 12.8-23.5), the 2-year survival was 82% (89% for primary NSCLC and 62% for metastases). After a median follow-up of 16.1 months (95% CI 11.2-21.1), local recurrences developed in 2 patients (4%). The 3-year local control rate was 97%, and just 1 patient developed grade ≥3 toxicity (chest wall pain). CONCLUSION MR-guided SF-SABR delivery to lung tumors on a 0.35 T linac, using repeated breath-holds with automatic beam gating, achieves good tumor control and low toxicity.
Collapse
Affiliation(s)
- Hilâl Tekatli
- Amsterdam UMC, location VUmc, Department of Radiation Oncology, Amsterdam, the Netherlands.
| | - Miguel A Palacios
- Amsterdam UMC, location VUmc, Department of Radiation Oncology, Amsterdam, the Netherlands
| | - Famke L Schneiders
- Amsterdam UMC, location VUmc, Department of Radiation Oncology, Amsterdam, the Netherlands
| | - Cornelis J A Haasbeek
- Amsterdam UMC, location VUmc, Department of Radiation Oncology, Amsterdam, the Netherlands
| | - Ben J Slotman
- Amsterdam UMC, location VUmc, Department of Radiation Oncology, Amsterdam, the Netherlands
| | - Frank J Lagerwaard
- Amsterdam UMC, location VUmc, Department of Radiation Oncology, Amsterdam, the Netherlands
| | - Suresh Senan
- Amsterdam UMC, location VUmc, Department of Radiation Oncology, Amsterdam, the Netherlands
| |
Collapse
|
3
|
Guzene L, Beddok A, Nioche C, Modzelewski R, Loiseau C, Salleron J, Thariat J. Assessing Interobserver Variability in the Delineation of Structures in Radiation Oncology: A Systematic Review. Int J Radiat Oncol Biol Phys 2023; 115:1047-1060. [PMID: 36423741 DOI: 10.1016/j.ijrobp.2022.11.021] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 11/04/2022] [Accepted: 11/09/2022] [Indexed: 11/23/2022]
Abstract
PURPOSE The delineation of target volumes and organs at risk is the main source of uncertainty in radiation therapy. Numerous interobserver variability (IOV) studies have been conducted, often with unclear methodology and nonstandardized reporting. We aimed to identify the parameters chosen in conducting delineation IOV studies and assess their performances and limits. METHODS AND MATERIALS We conducted a systematic literature review to highlight major points of heterogeneity and missing data in IOV studies published between 2018 and 2021. For the main used metrics, we did in silico analyses to assess their limits in specific clinical situations. RESULTS All disease sites were represented in the 66 studies examined. Organs at risk were studied independently of tumor site in 29% of reviewed IOV studies. In 65% of studies, statistical analyses were performed. No gold standard (GS; ie, reference) was defined in 36% of studies. A single expert was considered as the GS in 21% of studies, without testing intraobserver variability. All studies reported both absolute and relative indices, including the Dice similarity coefficient (DSC) in 68% and the Hausdorff distance (HD) in 42%. Limitations were shown in silico for small structures when using the DSC and dependence on irregular shapes when using the HD. Variations in DSC values were large between studies, and their thresholds were inconsistent. Most studies (51%) included 1 to 10 cases. The median number of observers or experts was 7 (range, 2-35). The intraclass correlation coefficient was reported in only 9% of cases. Investigating the feasibility of studying IOV in delineation, a minimum of 8 observers with 3 cases, or 11 observers with 2 cases, was required to demonstrate moderate reproducibility. CONCLUSIONS Implementation of future IOV studies would benefit from a more standardized methodology: clear definitions of the gold standard and metrics and a justification of the tradeoffs made in the choice of the number of observers and number of delineated cases should be provided.
Collapse
Affiliation(s)
- Leslie Guzene
- Department of Radiation Oncology, University Hospital of Amiens, Amiens, France
| | - Arnaud Beddok
- Department of Radiation Oncology, Institut Curie, Paris/Saint-Cloud/Orsay, France; Laboratory of Translational Imaging in Oncology (LITO), InsermUMR, Institut Curie, Orsay, France
| | - Christophe Nioche
- Laboratory of Translational Imaging in Oncology (LITO), InsermUMR, Institut Curie, Orsay, France
| | - Romain Modzelewski
- LITIS - EA4108-Quantif, Normastic, University of Rouen, and Nuclear Medicine Department, Henri Becquerel Center, Rouen, France
| | - Cedric Loiseau
- Department of Radiation Oncology, Centre François Baclesse; ARCHADE Research Community Caen, France; Département de Biostatistiques, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
| | - Julia Salleron
- Département de Biostatistiques, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
| | - Juliette Thariat
- Department of Radiation Oncology, Centre François Baclesse; ARCHADE Research Community Caen, France; Laboratoire de Physique Corpusculaire, Caen, France; Unicaen-Université de Normandie, Caen, France.
| |
Collapse
|
4
|
Leary D, Basran PS. The role of artificial intelligence in veterinary radiation oncology. Vet Radiol Ultrasound 2022; 63 Suppl 1:903-912. [PMID: 36514233 DOI: 10.1111/vru.13162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2021] [Revised: 01/21/2022] [Accepted: 04/12/2022] [Indexed: 12/15/2022] Open
Abstract
Veterinary radiation oncology regularly deploys sophisticated contouring, image registration, and treatment planning optimization software for patient care. Over the past decade, advances in computing power and the rapid development of neural networks, open-source software packages, and data science have been realized and resulted in new research and clinical applications of artificial intelligent (AI) systems in radiation oncology. These technologies differ from conventional software in their level of complexity and ability to learn from representative and local data. We provide clinical and research application examples of AI in human radiation oncology and their potential applications in veterinary medicine throughout the patient's care-path: from treatment simulation, deformable registration, auto-segmentation, automated treatment planning and plan selection, quality assurance, adaptive radiotherapy, and outcomes modeling. These technologies have the potential to offer significant time and cost savings in the veterinary setting; however, since the range of usefulness of these technologies have not been well studied nor understood, care must be taken if adopting AI technologies in clinical practice. Over the next several years, some practical and realizable applications of AI in veterinary radiation oncology include automated segmentation of normal tissues and tumor volumes, deformable registration, multi-criteria plan optimization, and adaptive radiotherapy. Keys in achieving success in adopting AI in veterinary radiation oncology include: establishing "truth-data"; data harmonization; multi-institutional data and collaborations; standardized dose reporting and taxonomy; adopting an open access philosophy, data collection and curation; open-source algorithm development; and transparent and platform-independent code development.
Collapse
Affiliation(s)
- Del Leary
- Department of Environment and Radiological Health Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA
| | - Parminder S Basran
- Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA
| |
Collapse
|
5
|
Lenkowicz J, Votta C, Nardini M, Quaranta F, Catucci F, Boldrini L, Vagni M, Menna S, Placidi L, Romano A, Chiloiro G, Gambacorta MA, Mattiucci GC, Indovina L, Valentini V, Cusumano D. A deep learning approach to generate synthetic CT in low field MR-guided radiotherapy for lung cases. Radiother Oncol 2022; 176:31-38. [PMID: 36063982 DOI: 10.1016/j.radonc.2022.08.028] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Revised: 08/23/2022] [Accepted: 08/24/2022] [Indexed: 12/14/2022]
Abstract
INTRODUCTION This study aims to apply a conditional Generative Adversarial Network (cGAN) to generate synthetic Computed Tomography (sCT) from 0.35 Tesla Magnetic Resonance (MR) images of the thorax. METHODS Sixty patients treated for lung lesions were enrolled and divided into training (32), validation (8), internal (10,TA) and external (10,TB) test set. Image accuracy of generated sCT was evaluated computing the mean absolute (MAE) and mean error (ME) with respect the original CT. Three treatment plans were calculated for each patient considering MRI as reference image: original CT, sCT (pure sCT) and sCT with GTV density override (hybrid sCT) were used as Electron Density (ED) map. Dose accuracy was evaluated comparing treatment plans in terms of gamma analysis and Dose Volume Histogram (DVH) parameters. RESULTS No significant difference was observed between the test sets for image and dose accuracy parameters. Considering the whole test cohort, a MAE of 54.9 ± 10.5 HU and a ME of 4.4 ± 7.4 HU was obtained. Mean gamma passing rates for 2%/2mm, and 3%/3mm tolerance criteria were 95.5 ± 5.9% and 98.2 ± 4.1% for pure sCT, 96.1 ± 5.1% and 98.5 ± 3.9% for hybrid sCT: the difference between the two approaches was significant (p = 0.01). As regards DVH analysis, differences in target parameters estimation were found to be within 5% using hybrid approach and 20% using pure sCT. CONCLUSION The DL algorithm here presented can generate sCT images in the thorax with good image and dose accuracy, especially when the hybrid approach is used. The algorithm does not suffer from inter-scanner variability, making feasible the implementation of MR-only workflows for palliative treatments.
Collapse
Affiliation(s)
- Jacopo Lenkowicz
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | - Claudio Votta
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy; Mater Olbia Hospital, Olbia (SS), Italy.
| | - Matteo Nardini
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | | | | | - Luca Boldrini
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | - Marica Vagni
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | | | - Lorenzo Placidi
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | - Angela Romano
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | - Giuditta Chiloiro
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | | | - Gian Carlo Mattiucci
- Mater Olbia Hospital, Olbia (SS), Italy; Università Cattolica del Sacro Cuore, Rome, Italy
| | - Luca Indovina
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy
| | - Vincenzo Valentini
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy
| | - Davide Cusumano
- Fondazione Policlinico Universitario ''Agostino Gemelli'' IRCCS, Rome, Italy; Mater Olbia Hospital, Olbia (SS), Italy
| |
Collapse
|
6
|
Kumar S, Holloway L, Boxer M, Ling Yap M, Chlap P, Moses D, Vinod S. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for Lung radiotherapy. Radiother Oncol 2021; 167:292-299. [PMID: 34896156 DOI: 10.1016/j.radonc.2021.11.036] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2021] [Revised: 11/30/2021] [Accepted: 11/30/2021] [Indexed: 10/19/2022]
Abstract
PURPOSE To compare gross tumour volume (GTV) delineation of lung cancer on magnetic resonance imaging (MRI) and positron emission tomography (PET) versus computed tomography (CT) and PET. METHODS Three experienced thoracic radiation oncologists delineated GTVs on twenty-six patients with lung cancer, based on CT registered to PET, T2-weighted MRI registered to PET and T1-weighted MRI registered with PET. All observers underwent education on reviewing T1 and T2 images along with guidance on window and level setup. Interobserver and intermodality variation was performed based ondice similarity coefficient (DSC), Hausdorff distance (HD), and average Hausdorff distance (AvgHD) metrics. To compute interobserver variability (IOV) a simultaneous truth and performance level estimation (STAPLE) volume for each image modality was used as reference volume. For intermodality analysis, each observers CT based primary and nodal GTV was used as reference volume. RESULTS A mean DSC of 0.9 across all observers for primary GTV (GTVp) and a DSC of > 0.7 for nodal GTV (GTVn) was demonstrated for IOV. Mean T2 and T1 GTVp and GTVn were smaller than CT GTVp and GTVn but the difference in volume between modalities was not statistically significant. Significant difference (p<0.01) for GTVp and GTVn was found between T2 and T1 GTVp and GTVn compared to CT GTVp and GTVn based on DSC metrics. Large variation in volume similarity was noted based on HD of up-to 5.4cm for observer volumes compared to STAPLE volume. CONCLUSION Interobserver variability in GTV delineation was similar for MRI and PET versus CT and PET. The significant difference between MRI compared to CT delineated volumes needs to be further explored.
Collapse
Affiliation(s)
- Shivani Kumar
- South West Sydney Cancer Services, Liverpool, NSW, Australia; Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia; South Western Sydney Clinical School, University of New South Australia, Sydney, NSW, Australia
| | - Lois Holloway
- South West Sydney Cancer Services, Liverpool, NSW, Australia; Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia; South Western Sydney Clinical School, University of New South Australia, Sydney, NSW, Australia; Institute of Medical Physics, School of Physics, University of Sydney, Sydney, NSW Australia; School of Mathematical and Physical Sciences, University of Newcastle, Newcastle, NSW Australia; Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW Australia
| | - Miriam Boxer
- South West Sydney Cancer Services, Liverpool, NSW, Australia; ICON Cancer Centre, Concord, NSW, Australia
| | - Mei Ling Yap
- South West Sydney Cancer Services, Liverpool, NSW, Australia; Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia; South Western Sydney Clinical School, University of New South Australia, Sydney, NSW, Australia; School of Medicine, Western Sydney University, Campbelltown, NSW, Australia; Sydney Medical School, Public Health, University of Sydney, Sydney, NSW, Australia
| | - Phillip Chlap
- South West Sydney Cancer Services, Liverpool, NSW, Australia; Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia; South Western Sydney Clinical School, University of New South Australia, Sydney, NSW, Australia
| | - Daniel Moses
- Prince of Wales Hospital, Sydney, NSW, Australia; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW, Australia
| | - Shalini Vinod
- South West Sydney Cancer Services, Liverpool, NSW, Australia; Ingham Institute for Applied Medical Research, Liverpool, NSW, Australia; South Western Sydney Clinical School, University of New South Australia, Sydney, NSW, Australia
| |
Collapse
|
7
|
许 文, 王 长, 马 一, 方 春, 巩 汉, 张 高, 曲 宝, 徐 寿. [Advances in magnetic resonance imaging guided radiation therapy]. SHENG WU YI XUE GONG CHENG XUE ZA ZHI = JOURNAL OF BIOMEDICAL ENGINEERING = SHENGWU YIXUE GONGCHENGXUE ZAZHI 2021; 38:161-168. [PMID: 33899441 PMCID: PMC10307565 DOI: 10.7507/1001-5515.202002029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 02/17/2020] [Revised: 10/16/2020] [Indexed: 11/03/2022]
Abstract
Image-guided radiation therapy using magnetic resonance imaging (MRI) is a new technology that has been widely studied and developed in recent years. The technology combines the advantages of MRI imaging, and can offer online real-time tracking of tumor and adjacent organs at risk, as well as real-time optimization of radiotherapy plan. In order to provide a comprehensive understanding of this technology, and to grasp the international development and trends in this field, this paper reviews and summarizes related researches, so as to make the researchers and clinical personnel in this field to understand recent status of this technology, and carry out corresponding researches. This paper summarizes the advantages of MRI and the research progress of MRI linear accelerator (MR-Linac), online guidance, adaptive optimization, and dosimetry-related research. Possible development direction of these technologies in the future is also discussed. It is expected that this review can provide a certain reference value for clinician and related researchers to understand the research progress in the field.
Collapse
Affiliation(s)
- 文哲 许
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
- 一洲肿瘤医院 放疗科(河北涿州 072750)Department of Radiotherapy, Yizhou Tumor Hospital, Zhuozhou, Hebei 072750, P. R. China
| | - 长建 王
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
- 一洲肿瘤医院 放疗科(河北涿州 072750)Department of Radiotherapy, Yizhou Tumor Hospital, Zhuozhou, Hebei 072750, P. R. China
| | - 一鸣 马
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
- 一洲肿瘤医院 放疗科(河北涿州 072750)Department of Radiotherapy, Yizhou Tumor Hospital, Zhuozhou, Hebei 072750, P. R. China
| | - 春锋 方
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
| | - 汉顺 巩
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
| | - 高龙 张
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
- 一洲肿瘤医院 放疗科(河北涿州 072750)Department of Radiotherapy, Yizhou Tumor Hospital, Zhuozhou, Hebei 072750, P. R. China
| | - 宝林 曲
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
- 一洲肿瘤医院 放疗科(河北涿州 072750)Department of Radiotherapy, Yizhou Tumor Hospital, Zhuozhou, Hebei 072750, P. R. China
| | - 寿平 徐
- 北京航空航天大学 物理学院(北京 100191)School of Physics, Beihang University, Beijing 100191, P. R.China
- 一洲肿瘤医院 放疗科(河北涿州 072750)Department of Radiotherapy, Yizhou Tumor Hospital, Zhuozhou, Hebei 072750, P. R. China
| |
Collapse
|
8
|
Hama Y, Tate E. Comparison of gross tumor volumes of pulmonary metastasis defined by CT and MRI in 0.345 T MRI-guided radiotherapy. BJR Open 2020; 2:20200010. [PMID: 33178974 PMCID: PMC7594882 DOI: 10.1259/bjro.20200010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Revised: 05/30/2020] [Accepted: 07/17/2020] [Indexed: 11/27/2022] Open
Abstract
OBJECTIVE To assess the difference in gross tumor volumes (GTVs) defined by CT (GTV-CT) and by low magnetic field strength (0.345 T) MRI (GTV-MRI) in patients simulated for MRI-guided radiotherapy forlung metastasis. METHODS 28 patients (148 lesions) who underwent CT and MRI simulation with the tri-60Co MRI-guided radiotherapy system (MRIdian, ViewRay) were included in this study. GTV-CT and GTV-MRI were compared using the paired t-test. The equivalence of variance between GTV-CT and GTV-MRI of small lesions (GTV-CT <1 ml) and large ones (GTV-CT >= 1 ml) was evaluated using F-test. The correlation between GTV-CT and GTV-MRI was evaluated by the correlation coefficient. RESULTS GTV-MRI was 120% larger than GTV-CT (p < 0.001) for small lesions, whereas GTV-MRI was 40% larger than GTV-CT (p < 0.001) for large lesions. In small lesions, the variation in GTV-MRI was significantly larger than that of GTV-CT (p < 0.001). There was no significant difference in the variation of GTV-MRI and GTV-CT in large lesions (p = 0.121). The correlation coefficient for small lesions was 0.93, whereas that for large lesions was 0.99, with large lesions having better correlation. CONCLUSIONS GTV-MRI was larger than GTV-CT and the correlation between GTV-MRI and GTV-CT was better in large lesions. If the tumor volume is 1 ml or larger, the lesion can be accurately monitored even with a low magnetic field strength MRI. ADVANCES IN KNOWLEDGE This study is the first clinical report to evaluate the tolerability of MRI images in 0.345 T MRI-guided radiotherapy for lung metastasis. GTV contoured by MRI was larger than GTV by CT, and this tendency was more pronounced in small tumors of less than 1 ml.
Collapse
Affiliation(s)
- Yukihiro Hama
- Department of Radiation Oncology, Tokyo-Edogawa Cancer Centre, Edogawa Hospital, Tokyo, Japan
| | - Etsuko Tate
- Department of Radiation Oncology, Tokyo-Edogawa Cancer Centre, Edogawa Hospital, Tokyo, Japan
| |
Collapse
|
9
|
Finazzi T, Palacios MA, Haasbeek CJ, Admiraal MA, Spoelstra FO, Bruynzeel AM, Slotman BJ, Lagerwaard FJ, Senan S. Stereotactic MR-guided adaptive radiation therapy for peripheral lung tumors. Radiother Oncol 2020; 144:46-52. [DOI: 10.1016/j.radonc.2019.10.013] [Citation(s) in RCA: 38] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Revised: 09/25/2019] [Accepted: 10/18/2019] [Indexed: 12/22/2022]
|
10
|
Chin S, Eccles CL, McWilliam A, Chuter R, Walker E, Whitehurst P, Berresford J, Van Herk M, Hoskin PJ, Choudhury A. Magnetic resonance-guided radiation therapy: A review. J Med Imaging Radiat Oncol 2020; 64:163-177. [PMID: 31646742 DOI: 10.1111/1754-9485.12968] [Citation(s) in RCA: 89] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2019] [Accepted: 09/24/2019] [Indexed: 12/11/2022]
Abstract
Magnetic resonance-guided radiation therapy (MRgRT) is a promising approach to improving clinical outcomes for patients treated with radiation therapy. The roles of image guidance, adaptive planning and magnetic resonance imaging in radiation therapy have been increasing over the last two decades. Technical advances have led to the feasible combination of magnetic resonance imaging and radiation therapy technologies, leading to improved soft-tissue visualisation, assessment of inter- and intrafraction motion, motion management, online adaptive radiation therapy and the incorporation of functional information into treatment. MRgRT can potentially transform radiation oncology by improving tumour control and quality of life after radiation therapy and increasing convenience of treatment by shortening treatment courses for patients. Multiple groups have developed clinical implementations of MRgRT predominantly in the abdomen and pelvis, with patients having been treated since 2014. While studies of MRgRT have primarily been dosimetric so far, an increasing number of trials are underway examining the potential clinical benefits of MRgRT, with coordinated efforts to rigorously evaluate the benefits of the promising technology. This review discusses the current implementations, studies, potential benefits and challenges of MRgRT.
Collapse
Affiliation(s)
- Stephen Chin
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
- Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia
| | - Cynthia L Eccles
- Department of Radiotherapy, The Christie NHS Foundation Trust, Manchester, UK
- Division of Cancer Sciences, The University of Manchester, Manchester, UK
| | - Alan McWilliam
- Division of Cancer Sciences, The University of Manchester, Manchester, UK
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
| | - Robert Chuter
- Division of Cancer Sciences, The University of Manchester, Manchester, UK
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
| | - Emma Walker
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
| | - Philip Whitehurst
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
| | - Joseph Berresford
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
| | - Marcel Van Herk
- Division of Cancer Sciences, The University of Manchester, Manchester, UK
- Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK
| | - Peter J Hoskin
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
- Division of Cancer Sciences, The University of Manchester, Manchester, UK
| | - Ananya Choudhury
- Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK
- Division of Cancer Sciences, The University of Manchester, Manchester, UK
| |
Collapse
|
11
|
Redler G, Stevens T, Cammin J, Malin M, Green O, Mutic S, Pitroda S, Aydogan B. Dosimetric Feasibility of Utilizing the ViewRay Magnetic Resonance Guided Linac System for Image-guided Spine Stereotactic Body Radiation Therapy. Cureus 2019; 11:e6364. [PMID: 31938646 PMCID: PMC6957030 DOI: 10.7759/cureus.6364] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Introduction: Spine stereotactic body radiation therapy (SBRT) achieves favorable outcomes compared to conventional radiotherapy doses/fractionation. The spinal cord is the principal dose-limiting organ-at-risk (OAR), and safe treatment requires precise immobilization/localization. Therefore, image guidance is paramount to successful spine SBRT. Conventional X-ray imaging and alignment to surrogate bony anatomy may be inadequate, whereas magnetic resonance imaging (MRI) directly visualizes the dose-limiting cord. This work assessed the dosimetric capability of the ViewRay (ViewRay Inc. Oakwood Village, OH) magnetic resonance (MR) guided linac (MR-Linac) for spine SBRT. Methods: Eight spine SBRT patients without orthopedic hardware who were previously treated on a TrueBeam using volumetric modulated arc therapy (VMAT) were re-planned using MR-Linac fixed-field intensity-modulated radiation therapy (IMRT). Phantom measurements using film, ionization chamber, and a commercial diode-array assessed feasibility. Plans included a variety of prescriptions (30-50 Gy in 3-10 fractions). Results: MR-Linac plans satisfied all clinical goals. Compared to VMAT plans, both entrance dose and heterogeneity increased (Dmax: 134±3% vs. 120±2%, p=0.0270), while conformality decreased (conformity index: 1.28±0.06 vs. 1.06±0.06, p=0.0005), and heterogeneity increased. However, while not statistically significant, MR-linac cord sparing improved (cord Dmax: 16.1±2.7Gy vs. 19.5±1.6Gy, p=0.2066; cord planning organ at risk volume (cord PRV) Dmax: 20.0±2.6Gy vs. 24.5±2.0Gy, p=0.0996). Delivery time increased but was acceptable (14.39±1.26min vs. 9.57±1.19min). Ionization chamber measurements agreed with planned dose to within 2.5%. Film and diode measurements demonstrated accurate/precise delivery of dose gradients between the target and the cord. Conclusion: Spine SBRT with the MR-Linac is feasible as verified via re-planning eight clinical cases followed by delivery verification in phantoms using film, diodes, and an ionization chamber. Real-time visualization of the dose-limiting cord during spine SBRT may enable cord-based gating, reduced margins, alternate dose schemas, and/or adaptive therapy.
Collapse
Affiliation(s)
- Gage Redler
- Radiation Oncology, Moffitt Cancer Center, Tampa, USA
| | | | - Jochen Cammin
- Radiation Oncology, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, USA
| | - Martha Malin
- Radiation Oncology, New York University, Langone Medical Center & Laura and Issac Perlmutter Cancer Center, New York, USA
| | - Olga Green
- Radiation Oncology, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, USA
| | - Sasa Mutic
- Radiation Oncology, Washington University School of Medicine, Barnes-Jewish Hospital, St. Louis, USA
| | - Sean Pitroda
- Radiation and Cellular Oncology, University of Chicago, Chicago, USA
| | - Bulent Aydogan
- Radiation and Cellular Oncology, University of Chicago, Chicago, USA
| |
Collapse
|
12
|
Kiser KJ, Smith BD, Wang J, Fuller CD. "Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era. Front Oncol 2019; 9:983. [PMID: 31632914 PMCID: PMC6779062 DOI: 10.3389/fonc.2019.00983] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2019] [Accepted: 09/16/2019] [Indexed: 12/17/2022] Open
Abstract
Magnetic resonance imaging provides a sea of quantitative and semi-quantitative data. While radiation oncologists already navigate a pool of clinical (semantic) and imaging data, the tide will swell with the advent of hybrid MRI/linear accelerator devices and increasing interest in MRI-guided radiotherapy (MRIgRT), including adaptive MRIgRT. The variety of MR sequences (of greater complexity than the single parameter Hounsfield unit of CT scanning routinely used in radiotherapy), the workflow of adaptive fractionation, and the sheer quantity of daily images acquired are challenges for scaling this technology. Biomedical informatics, which is the science of information in biomedicine, can provide helpful insights for this looming transition. Funneling MRIgRT data into clinically meaningful information streams requires committing to the flow of inter-institutional data accessibility and interoperability initiatives, standardizing MRIgRT dosimetry methods, streamlining MR linear accelerator workflow, and standardizing MRI acquisition and post-processing. This review will attempt to conceptually ford these topics using clinical informatics approaches as a theoretical bridge.
Collapse
Affiliation(s)
- Kendall J Kiser
- John P. and Kathrine G. McGovern Medical School, University of Texas Health Science Center, Houston, TX, United States.,School of Biomedical Informatics, University of Texas Health Science Center, Houston, TX, United States.,Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States
| | - Benjamin D Smith
- Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States
| | - Jihong Wang
- Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX, United States
| | - Clifton D Fuller
- Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States
| |
Collapse
|
13
|
Stieb S, McDonald B, Gronberg M, Engeseth GM, He R, Fuller CD. Imaging for Target Delineation and Treatment Planning in Radiation Oncology: Current and Emerging Techniques. Hematol Oncol Clin North Am 2019; 33:963-975. [PMID: 31668214 DOI: 10.1016/j.hoc.2019.08.008] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Imaging in radiation oncology has a wide range of applications. It is necessary not only for tumor staging and treatment response assessment after therapy but also for the treatment planning process, including definition of target and organs at risk, as well as treatment plan calculation. This article provides a comprehensive overview of the main imaging modalities currently used for target delineation and treatment planning and gives insight into new and promising techniques.
Collapse
Affiliation(s)
- Sonja Stieb
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
| | - Brigid McDonald
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
| | - Mary Gronberg
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
| | - Grete May Engeseth
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
| | - Renjie He
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
| | - Clifton David Fuller
- Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
| |
Collapse
|
14
|
Zhu J, Xu Y, Lu XJ. Stereotactic Body Radiation Therapy and Ablative Therapies for Solid Tumors: Recent Advances and Clinical Applications. Technol Cancer Res Treat 2019; 18:1533033819830720. [PMID: 30922170 PMCID: PMC6444407 DOI: 10.1177/1533033819830720] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Affiliation(s)
- Jing Zhu
- 1 Department of General Surgery, Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.,2 The Sparkfire Scientific Research Group of Nanjing Medical University, Nanjing, China
| | - Yong Xu
- 3 Department of Nephrology, Huai'an Second People's Hospital and The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China
| | - Xiao-Jie Lu
- 1 Department of General Surgery, Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
| |
Collapse
|